By (author): Demosthenes Katritsis, A. John Camm, Bernard J. Gersh
Clinical Cardiology: Current Practice Guidelines Updated Edition is an essential tool for the busy clinician, offering succinct yet detailed access to the most recent trial and guideline data supporting practice and patient management in cardiology.
ESC and ACC/AHA guidelines are continually updated and often overlap in their advice, making it difficult for the cardiologist to obtain a clear picture of the right way to diagnose and treat disease according to the latest evidence base. Written by leading authorities in the field, this book, together with its regularly-updated online version, provides a unique solution.
The authors have scrutinized all available guidelines and research from both ACC/AHS and ESC on every clinical issue. The result is a rigorous examination of the implications of published guidance, illustrated by more than 600 easy-to-follow tables and 200 full-colour images, which reinforce key points and clarify difficult concepts.
87 comprehensive chapters explore the definition, epidemiology, pathophysiology, diagnosis and management of cardiac disease. Two new chapters examine the univentricular heart and venous thrombembolism. Each chapter encompasses the latest published research, followed by discussions of possible presentations and investigations, offering detailed insights for clinicians into best practice for diagnosis and treatment.
Providing at-a-glance access to the best guidance in cardiology, this book offers a diagnosis and management toolkit which no practising cardiologist can afford to be without.
This user-friendly review question book is geared to interventional cardiology board candidates either for initial certification or recertification. It contains 900 questions in the same proportion as the actual exam to ensure highly targeted, high-yield preparation. Answers with brief explanations and references are included. Indications for particular procedures—a major focus of the board exam—are integrated throughout the text, particularly in the context of ACC/AHA guidelines.
More than 250 angiograms and other illustrations reinforce key concepts. Separate chapters cover ACC/AHA guidelines for percutaneous coronary intervention, chronic stable angina, acute coronary syndromes, and ST-elevation myocardial infarction. A chapter on test-taking is also included.
Clinical Guide to Cardiology is a quick-reference resource, packed full of bullet points, diagrams, tables and algorithms for the key concepts and facts for important presentations and conditions within cardiology. It provides practical, evidence-based information on interventions, investigations, and the management of clinical cardiology.
Key features include: • A clear evidence-base providing key guidelines and clinical trials in each chapter • Coverage of examination techniques, common conditions, imaging modalities (including ECGs, chest X-rays, MRI and CT), interventional therapies, and pharmacology • A companion website at www.wiley.com/go/camm/cardiology featuring audio clips, developed for differing levels of knowledge, that explain key concepts or an area in greater detail, as well as numerous additional clinical case studies, audio scripts, and self-assessment material
At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. But that’s changing, thanks to technological advances. Interventions in Structural, Valvular, and Congenital Heart Disease, Second Edition guides you throught the interventional treatment of congenital, valvular, and structural heart disease in the children and adults. The book emphasizes the practical aspects of procedures and covers other important areas such as indications and patient selection, potential pitfalls, and complications.
See What’s New in the Second Edition:
Contributions from new authors who are pioneers in structural interventions in adults and transcatheter aortic valve replacement
Expanded emphasis on the importance of imaging alongside the technical details of equipment and its safe and effective delivery
Coverage of emerging techniques at the forefront of interventional treatment such as fetal interventions, hybrid procedures, and mitral valve repair
Greater understanding, technical knowhow, and wider availability of catheters, balloons, delivery systems, and devices have spread intervention into the realm of acquired valve disease, degenerative disease of the aorta, paravalve leakage, postinfarction ventricular septal defects, and closure of the left atrial appendage. The book draws together expert interventionists from throughout the world to present approaches to congenital and structural heart disease that results in better outcomes for patients.
Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management provides a comprehensive, up-to-date overview of care of the pediatric patient undergoing cardiac surgery and anesthesia. After introductory chapters that encompass pediatric cardiovascular embryology, physiology and pharmacology, diagnostic approaches and preoperative considerations are explained. The intraoperative management of a wide range of specific lesions is then discussed, with full descriptions of anesthesia plans added with descriptions on diagnostic methods and surgical interventions. Postoperative care is also addressed, and a concluding section considers anesthesia outside the cardiac operating room.
In the twenty-first century, advances in minimally invasive technology have led to the introduction of a wide array of pediatric cardiac procedures. More traditional surgical procedures have also been transformed by new devices and surgical approaches. The cardiac anesthesiologist is faced with an ever-increasing role in the perioperative care of pediatric patients undergoing cardiologic procedures in operating rooms, as well as less conventional locations. In this book, accomplished experts from around the world in the fields of pediatric anesthesia, cardiology, and cardiac surgery describe the multiple facets of caring for this very unique patient population.
This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.
This book focuses specifically on the management of cardiovascular disease in elderly patients with particular frailties and in the “oldest old”. It is clearly explained how treatment in these patients differs from that in patients in their seventies who respond well to therapies and do not present frailties or organ failures. Although not young, the latter patients can be treated almost like any other patient, according to established guidelines. In contrast, the frail, compromised elderly and the oldest old require specific measures that target their needs, including with respect to underlying renal conditions. The book considers all those pathologies that have a high prevalence in the general population, explaining advanced treatment concepts and all aspects of assessment. Key clinical points are highlighted, and the text is supplemented with numerous informative figures and tables. The authors are respected experts, for the most part geriatric physicians, and the book is especially addressed to cardiologists, who may lack the described targeted information and treatment tools.